AVCO Description — Avalon GloboCare Corp
Avalon GloboCare is a holding company. Through its subsidiaries, Co. is a clinical-stage CellTech bio-developer focused on advancing and empowering transformative immune effector cell therapy, exosome technology, as well as Coronavirus Disease 2019 (COVID-19) related diagnostics and therapeutics. Co. also provides advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as engage in healthcare and CellTech industry markets. Co. is engaging in the fields of cellular immunotherapy (including chimeric antigen receptor-T/NK), exosome technology (Avalon Clinical-grade Tissue-specific Exosome), and COVID-19 related vaccine and therapeutics.